<?xml version="1.0" encoding="UTF-8"?>
<p id="Par77">ACCoRd protocol incorporates four planned translational research studies:
 <list list-type="bullet">
  <list-item>
   <p id="Par78">Biomarker exploration of prognosis determination: interphase fluorescent in situ hybridisation (iFISH) vs. next generation sequencing (NGS)-based molecular analysis</p>
  </list-item>
  <list-item>
   <p id="Par79">MRD detection: comparative analysis of multi-parameter flow cytometry (MFC) and NGS-based molecular analysis</p>
  </list-item>
  <list-item>
   <p id="Par80">Biomarker discovery for proteasome inhibitor sensitivity</p>
  </list-item>
  <list-item>
   <p id="Par81">Immune biomarker discovery: exploration of immune functional assessment, including immune senescence, in relation to patient outcomes and response to therapy.</p>
  </list-item>
 </list>
</p>
